Scientists found that aggressive lung cancer cells create their own electrical network, helping them spread. This unique ...

About 50% of those who have lung cancer will develop brain mets. And around 25% already have them at the time of diagnosis. If you have metastatic lung cancer, the odds of survival are poor.

Non-small cell lung cancer that has metastasized may cause different symptoms depending on where it has spread. Treatment can help reduce symptoms and prolong life. Non-small cell lung cancer ...

Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo ...

As an expert explained in an interview with CURE, we may be in the midst of a “new era” for small cell lung cancer research.

Savolitinib is an oral, potent and highly selective MET tyrosine kinase inhibitor ("TKI”) being jointly developed and commercialized by AstraZeneca and HUTCHMED. In 2023, savolitinib and TAGRISSO ® ...

When diagnosing lung metastases and second primary lung cancer in patients with head and neck cancer, low-dose CT leads to better sensitivity than chest x-ray but does not lead to improved overall ...

The FDA granted orphan drug status to rhenium-186 obisbemeda for treating leptomeningeal metastases in lung cancer.